BMC-run hospitals have successfully tried an immunomodulatory drug to treat extremely critical Covid-19 cases. The drug, which costs Rs 60,000-a-doze, was administered to two patients in Nair Hospital and both showed remarkable recovery.from Industry-Economic Times
Read The Rest:economictimes...
